4.7 Article

Coronavirus Disease 2019 (COVID-19) Diagnostic Clinical Decision Support: A Pre-Post Implementation Study of CORAL (COvid Risk cALculator)

期刊

CLINICAL INFECTIOUS DISEASES
卷 73, 期 12, 页码 2248-2256

出版社

OXFORD UNIV PRESS INC
DOI: 10.1093/cid/ciab111

关键词

COVID-19 diagnosis; electronic health record; diagnostic algorithm; clinical decision support system

资金

  1. Massachusetts General Hospital Infection Control Unit departmental funds
  2. National Institute of Allergy and Infectious Diseases [R37AI058736-16S1, T32AI007061, K08AI14755]
  3. Eunice Kennedy Shriver National Institute of Child Health and Human Development [K08HD101342]
  4. Centers for Disease Control and Prevention [U01CK000490]
  5. Cystic Fibrosis Foundation
  6. Sullivan Family Foundation
  7. Roger I. and Ruth B. MacFarlane Foundation
  8. Harvard Catalyst

向作者/读者索取更多资源

The use of the CORAL system for evaluating PUIs can reduce repeated testing, shorten the time for PUI status discontinuation, and decrease infectious diseases physician work hours, making it an efficient and effective diagnostic method.
Background. Isolation of hospitalized persons under investigation (PUIs) for coronavirus disease 2019 (COVID-19) reduces nosocomial transmission risk. Efficient evaluation of PUIs is needed to preserve scarce healthcare resources. We describe the development, implementation, and outcomes of an inpatient diagnostic algorithm and clinical decision support system (CDSS) to evaluate PUIs. Methods. We conducted a pre-post study of CORAL (COvid Risk cALculator), a CDSS that guides frontline clinicians through a risk-stratified COVID-19 diagnostic workup, removes transmission-based precautions when workup is complete and negative, and triages complex cases to infectious diseases (ID) physician review. Before CORAL, ID physicians reviewed all PUI records to guide workup and precautions. After CORAL, frontline clinicians evaluated PUIs directly using CORAL. We compared pre- and post-CORAL frequency of repeated severe acute respiratory syndrome coronavirus 2 nucleic acid amplification tests (NAATs), time from NAAT result to PUI status discontinuation, total duration of PUI status, and ID physician work hours, using linear and logistic regression, adjusted for COVID-19 incidence. Results. Fewer PUIs underwent repeated testing after an initial negative NAAT after CORAL than before CORAL (54% vs 67%, respectively; adjusted odd ratio, 0.53 [95% confidence interval,.44-.63]; P < .01). CORAL significantly reduced average time to PUI status discontinuation (adjusted difference [standard error], -7.4 [0.8] hours per patient), total duration of PUI status (-19.5 [1.9] hours per patient), and average ID physician work-hours (-57.4 [2.0] hours per day) (all P < .01). No patients had a positive NAAT result within 7 days after discontinuation of precautions via CORAL. Conclusions. CORAL is an efficient and effective CDSS to guide frontline clinicians through the diagnostic evaluation of PUIs and safe discontinuation of precautions.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据